World's first malaria vaccine started in the pilot program


Malaysia remains one of the leading killers in the world and claims that the life of one child in every two minutes. Most of these deaths occur in Africa, where more than 250,000 children are diagnosed every year. Children under 5 are the biggest risk of life-threatening complications. Throughout the world, malaria kill 435,000 people a year, mostly children.

This week, a pilot program involving the implementation of Malawi Children's Immuno, the RTS vaccine vaccine has begun, and the vaccine may cause progress to combat the disease.

For thirty years, RTS, S is the first and only vaccine that has shown that it can reduce malaria children. In clinical trials the vaccine was found to prevent 10 malaria cases, including 10 cases of life-threatening malaria. Vaccine also reduced the level of severe anemia – the most common cause of children with illness – 60%.

4 dose schedule should be taken immediately after 5 months immediately after the first dose, once every two months and three months, and the fourth dose after a dose of 15-18 months. In the 3rd stage, the vaccine has generally been well and has negative reactions compared to other children's vaccines. The European Medicine Agency (EMA) has conducted research on RTS, S and concluded that the vaccine is available on a security profile profile in July 2015. The vaccine is an option for additional malaria controls – recommended by the WHO recommended recommended measures for malaria prevention, including routine use of injection-treated bed networks, injection synthetic injections, and timely use of malaria testing and treatment.

World Health Organization World Health Organization WHO Director General Tadoro Adhon Ghaletszus said that enormous achievements towards malaria during the last 15 years were made using bed and other measures, but progress has been delayed or altered in some areas.

"We need new solutions to get malaria to react back to the track, and this vaccine gives us a promising tool to get there," he said. "Malaria vaccine has the potential to save lives of tens of thousands of children."

Apart from Malawi, RTS's trial programs, as well as other routine children's vaccines, are also located in the selected areas of Ghana and Kenya. The WHO's Strategic Advisory Committee (SAGE) is working on recommendations for vaccination and its malaria policy advisory committee addresses the use of the vaccine public health.

In addition to the World Health Organization and the healthcare ministries of three countries, other groups that collaborate with the pilot program include PATH, which is based on a non-profit health care system. And the GSK imposes 10 million vaccine doses. The program is financed by three global health groups at a cost of $ 50 million: Gavi, Vaccine Alliance; Global Fund for AIDS, TB and Malaria fighting; And Unitaid.

The pilot program aims to reach 360,000 children annually in three years. The healthcare ministries will be guided wherever the vaccine is given, focusing on moderate-high transmission zones. The World Health Organization will use the results from the pilot program to make recommendations of its policy on the wide use of RTS, S vaccine. In particular, he will study the child's death, will be affected in the target population, parents will have children with four doses and the vaccine safety along with routine use.

Brian, director of the WHO Immunization, Vaccines and Biology Department, said that young babies are at high risk of severe consequences and as far as I am vaccinated to prevent disease in children and children, a new strategy.